Sort
82,697 grants matching “vaccine development”
Center for AIDS Research at Emory University
$3,327,667Carlos Del Rio · Emory University · P30 · FY2018 · AI
SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS
$3,324,580Barbara Driver · Westat, Inc. · N01 · FY2024 · HD
Core C Clinical Core
$3,323,570Michael J Mugavero · University Of Alabama At Birmingham · P30 · FY2020 · AI
A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)
$3,323,570Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2020 · AI
Developing Inhibitors of Seasonal and Pandemic Influenza Viruses
$3,323,410Richard K. Plemper · Georgia State University · R01 · FY2025 · AI
NIAID VIROLOGY QUALITY ASSURANCE
$3,320,440James Bremer · Rush University Medical Center · N01 · FY2018 · AI
ARRA: H1N1 and Other ARRA Equipment
$3,314,695Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2010 · AI
Malaria Vaccine Production and Support Services
$3,314,476Kathleen Kootz · Science Applications Inte · N01 · FY2013 · AI
University of Pennsylvania HIV Clinical Trials Unit
$3,313,023Ian Frank · University Of Pennsylvania · UM1 · FY2022 · AI
Primary Infection Resource Consortium (PIRC)
$3,311,878Susan Little · University Of California, San Diego · R24 · FY2017 · AI
Toxic substances in the environment
$3,311,386Martyn T Smith · University Of California Berkeley · P42 · FY2025 · ES
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
$3,311,110Jason Dickens · Duke University · U19 · FY2022 · AI
Adjuvant development in the context of seasonal and pandemic influenza
$3,308,745Jay Evans · University Of Montana · N01 · FY2019 · AI
Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines
$3,307,969Michael Gale · University Of Washington · N01 · FY2017 · AI
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$3,307,331Dana-Farber Cancer Institute · P01 · FY2004 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,304,387Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
The uptake and real-world effectiveness of emerging respiratory syncytial virus maternal vaccines and monoclonal antibodies on short- and long-term respiratory morbidities
$3,304,164Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2025 · AI
Multimodal PET-CT imaging of SIVmac239 dynamics post-ART interruption
$3,302,677Afamefuna Okoye · Oregon Health & Science University · R01 · FY2025 · AI
Centers for AIDS Research (CFAR)
$3,301,919Georgia D Tomaras · Duke University · P30 · FY2021 · AI
Vaccine Induced Immunity in the Young and Aged
$3,300,759Rafi Ahmed · Emory University · U19 · FY2010 · AI
Development of an VEE Replicon Vaccine Against Smallpox
$3,300,000Alphavax Human Vaccines, Inc. · UC1 · FY2005 · AI
Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory
$3,299,716Erin June Adams · University Of Chicago · G20 · FY2021 · AI
Towards high-resolution structural biology of membrane protein complexes in their native lipid environment
$3,299,641Doreen Matthies · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Task X3: Evaluation of Clinical Samples from Influenza Clinical Trials
$3,299,568Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI
GENERAL CLINICAL RESEARCH CENTER
$3,299,255New York University School Of Medicine · M01 · FY2000 · RR